These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2846400)

  • 21. Rapid regulation of apolipoprotein A-I secretion in HepG2 cells by a factor associated with bovine high-density lipoproteins.
    Ranganathan S; Kottke BA
    Biochim Biophys Acta; 1990 Sep; 1046(2):223-8. PubMed ID: 2171668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution of cholesterol and apoprotein A-I between the lipoproteins in plasma and peripheral lymph from normal human subjects.
    Rudra DN; Myant NB; Pflug JJ; Reichl D
    Atherosclerosis; 1984 Dec; 53(3):297-308. PubMed ID: 6442154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human proapolipoprotein A-II is cleaved following secretion from Hep G2 cells by a thiol protease.
    Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1984 Dec; 259(24):15556-63. PubMed ID: 6096378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro conversion of recombinant human proapolipoprotein A-I to apolipoprotein A-I.
    Saku K; Bai H; Hirata K; Liu R; Zhang B; Ohkubo K; Yamamoto K; Arakawa K
    Biochim Biophys Acta; 1994 Jan; 1217(1):29-30. PubMed ID: 8286413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of reversed-phase high-performance liquid chromatography to the separation of apolipoproteins A-IV, A-I and E from rat high-density lipoprotein.
    Meyer B; Kecorius E; Barter P; Fidge N; Tetaz T
    J Chromatogr; 1991 Mar; 540(1-2):386-91. PubMed ID: 1906476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Over-expression in Escherichia coli and characterization of apolipoprotein AI].
    Ding MS; Ma WF; Zhang MF; Liu DT; Guo MJ; Zhuang YP; Chu J; Zhang SL; Gong BQ
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):198-203. PubMed ID: 16013475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-poor apolipoprotein A-I in Hep G2 cells: formation of lipid-rich particles by incubation with dimyristoylphosphatidylcholine.
    Forte TM; Nichols AV; Selmek-Halsey J; Caylor L; Shore VG
    Biochim Biophys Acta; 1987 Aug; 920(3):185-94. PubMed ID: 3038192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Shen J; Huang CK; Yu H; Shen B; Zhang Y; Liang Y; Li Z; Feng X; Zhao J; Duan L; Cai X
    J Cell Mol Med; 2017 May; 21(5):986-992. PubMed ID: 28224705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human alpha 1-microglobulin in various hepatic disorders.
    Itoh Y; Enomoto H; Takagi K; Kawai T; Yamanaka T
    Digestion; 1983; 27(2):75-80. PubMed ID: 6195036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of prebeta HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells.
    Sawada S; Sugano M; Makino N; Okamoto H; Tsuchida K
    Atherosclerosis; 1999 Oct; 146(2):291-8. PubMed ID: 10532685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical localization of apolipoprotein A-I using polyclonal antibodies raised against the formaldehyde-modified antigen.
    Harrach B; Robenek H
    J Microsc; 1991 Jan; 161(Pt 1):97-108. PubMed ID: 1901913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
    von Eckardstein A; Funke H; Henke A; Altland K; Benninghoven A; Assmann G
    J Clin Invest; 1989 Dec; 84(6):1722-30. PubMed ID: 2512329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular processing of proapolipoprotein A-II in Hep G2 cell cultures is mediated by a 54-kDa protease immunologically related to cathepsin B.
    Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
    J Biol Chem; 1985 Nov; 260(27):14824-31. PubMed ID: 2414299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-I (Glu 198----Lys): a mutant of the major apolipoprotein of high-density lipoproteins occurring in a family with dyslipoproteinemia.
    Strobl W; Jabs HU; Hayde M; Holzinger T; Assmann G; Widhalm K
    Pediatr Res; 1988 Aug; 24(2):222-8. PubMed ID: 3141894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the metabolic behavior of rat apolipoproteins A-I and A-IV, isolated from both lymph chylomicrons and serum high density lipoproteins.
    Dallinga-Thie GM; van't Hooft FM; van Tol A
    Int J Biochem; 1986; 18(4):383-8. PubMed ID: 3086149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity in the conformation of apo A-I on the surface of HDL particles.
    Ayrault-Jarrier M; Bekaert E; Petit E; Pastier D; Polonovski J; Pau B; Paolucci F; Hervaud E; Laprade M
    Adv Exp Med Biol; 1988; 243():149-55. PubMed ID: 2464909
    [No Abstract]   [Full Text] [Related]  

  • 40. The basic apolipoprotein A-I in the patients with familial lecithin:cholesterol acyltransferase deficiency.
    Teramoto T; Kato H; Hashimoto Y; Kinoshita M; Oka H; Naito C
    Scand J Clin Lab Invest; 1986 Jun; 46(4):297-305. PubMed ID: 3088715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.